Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase NA 6Phase 1/2 5Phase EARLY_PHASE1 2Phase 3 2Phase 1 2

Status

Recruiting 2Withdrawn 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 1

Conditions

Multiple Myeloma 28Breast Neoplasms 23Neoplasms 21Pancreatic Neoplasms 17Prostatic Neoplasms 16Glioma 16Glioblastoma 16Recurrence 14Leukemia, Myeloid, Acute 14Solid Tumor 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma, Non-Hodgkin 12Brain Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Lung Neoplasms 9Triple Negative Breast Neoplasms 8Hematologic Neoplasms 8Melanoma 7Lymphoma, B-Cell 7Lymphoma 7Colorectal Neoplasms 7Polycystic Ovary Syndrome 6Neoplasm Metastasis 6Head and Neck Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Carcinoma, Hepatocellular 6Advanced Solid Tumors 6Myelodysplastic Syndromes 5Leukemia, Plasma Cell 5Leukemia 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Recruiting × Immunoglobulin Light-chain Amyloidosis × Clear all
NCT07626476 2026-06-04

Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis

Beijing Boren Hospital

Phase EARLY_PHASE1 Recruiting
30 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Recurrence

NCT07085559 2025-07-25

Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research

Anhui Provincial Hospital

Phase EARLY_PHASE1 Recruiting
36 enrolled
Other hematologic neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Leukemia, Plasma Cell, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡